EFFECT OF METABOLIC SYNDROME ON LEFT VENTRICULAR WALL MOTION IN PATIENTS WITH ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
The aim of our study was to determine the prevalence of metabolic syndrome in patients with ST segment elevation myocardial infarction and determine its effect on the size of myocardial infarction as estimated by cardiac enzymes and wall motion score index (WMSI) in this group of patients. Among 112 patients that were included in the study, 76 patients (67,8 %): 40 women and 36 men had metabolic syndrome. Patients with MetS were more likely to be females. Ejection fraction was lower in patients with MetS and they had a larger infarct size as determined by peak CK and CK-MB and WMSI. Results of the study demonstrated the significant negative effect of metabolic syndrome on left ventricular wall motion in patients with ST segment elevation myocardial infarction, and highlight the need for further studies aiming for optimizing the management of this group of patients.